Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5676301 | American Journal of Obstetrics and Gynecology | 2017 | 6 Pages |
Abstract
This study indicates that the contraceptive implant and 52-mg hormonal intrauterine device continue to be highly effective for at least 2 additional years of use. Serum etonogestrel evaluation demonstrates median levels remain above the ovulation threshold of 90 pg/mL for women in all body mass index classes.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Colleen DO, MSCI, Erin MD, Leping MPH, Jeffrey F. MD, PhD,